Efficacy of the Use of Silver Diamine Fluoride and Sodium Fluoride Varnish for the Treatment of Caries in Children
Launched by UNIVERSIDAD MAYOR DE SAN SIMÓN · Dec 1, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The patient must be able to receive all necessary treatments and may be followed up for additional treatments and/or record follow-ups at each time point and for the duration of the study.
- • Children within the age range mentioned above.
- • Require a completed informed consent form and completed nutritional survey record for anyone who will participate in the program.
- • According to the evaluation of the dentist Caries grade I and grade II
- • In the case of patients with disabilities, at least one parent or legal guardian must be present at all times during the study.
- Exclusion Criteria:
- • Patients who, after assessment, identify a pulp condition or abscess in any of the teeth, this affected piece will be excluded from receiving treatment with 38% silver diamine fluoride and 5% sodium fluoride varnish (in these cases, the Patient Coordinator will refer to a dentist outside the study for their treatment)
- • Patients with caries with grade III or grade IV
- • Patients with a known allergy to any of the active ingredients ( 38% silver diamine fluoride and 5% sodium fluoride varnish)
- • Patients who were unable to give their informed consent or complete the nutritional survey.
- • Patients who cannot participate during the entire program (12 months).
- • Patients with other oral treatments (Orthodontics).
- • Patients who are not present with at least one parent or legal guardian at the time of treatment.
Trial Officials
Nathaly Campero Ferrufino, DDS
Principal Investigator
Private University of the Valley
Ximena Claros Martinez, DDS
Principal Investigator
Private University of the Valley
Edwin Guarayo Molina, DDS
Principal Investigator
Private University of the Valley
Rodrigo k Arce Cardozo, MD, MPH,
Principal Investigator
Universidad Mayor de San Simon
Steve Duffin, DDS
Principal Investigator
NODK LLC
About Universidad Mayor De San Simón
Universidad Mayor de San Simón is a prestigious academic institution located in Bolivia, renowned for its commitment to advancing research and education in the health sciences. As a clinical trial sponsor, the university leverages its extensive resources and expertise to conduct rigorous clinical research aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Universidad Mayor de San Simón collaborates with various stakeholders to ensure the successful design, implementation, and dissemination of clinical trials that address pressing health challenges in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cochabamba, , Bolivia
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials